COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,491,756 | +44.3% | 666,245 | +64.7% | 0.02% | +57.1% |
| Q2 2023 | $1,726,980 | +150.8% | 404,445 | +301.7% | 0.01% | +366.7% |
| Q1 2023 | $688,720 | +72.7% | 100,690 | +100.0% | 0.00% | 0.0% |
| Q4 2022 | $398,732 | -17.6% | 50,345 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $484,000 | +28.0% | 50,345 | -3.6% | 0.01% | +66.7% |
| Q2 2022 | $378,000 | -51.2% | 52,200 | -13.0% | 0.00% | -50.0% |
| Q1 2022 | $775,000 | -19.1% | 60,000 | 0.0% | 0.01% | -14.3% |
| Q4 2021 | $958,000 | -20.6% | 60,000 | -20.1% | 0.01% | -22.2% |
| Q3 2021 | $1,207,000 | +15.1% | 75,106 | -0.9% | 0.01% | +12.5% |
| Q2 2021 | $1,049,000 | -83.3% | 75,819 | -79.0% | 0.01% | -84.6% |
| Q4 2020 | $6,263,000 | +10.4% | 360,344 | +16.5% | 0.05% | -7.1% |
| Q3 2020 | $5,672,000 | +107.6% | 309,224 | +102.2% | 0.06% | +100.0% |
| Q2 2020 | $2,732,000 | – | 152,935 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |